Primary Definitive Treatment versus Ureteric Stenting in the Management of Acute Ureteric Colic: A Cost-Effectiveness Analysis

被引:0
|
作者
Sehgal, Radha [1 ]
Abu-Ghanem, Yasmin [1 ]
Fontaine, Christina [1 ]
Forster, Luke [1 ]
Goyal, Anuj [1 ]
Allen, Darrell [1 ]
Kucheria, Rajesh [1 ]
Singh, Paras [1 ]
Ellis, Gidon [1 ]
Ajayi, Leye [1 ]
机构
[1] Royal Free London NHS Fdn Trust, Dept Urol, London NW3 2QG, England
来源
JOURNAL OF PERSONALIZED MEDICINE | 2022年 / 12卷 / 11期
关键词
ureteric stones; temporising measures; ureteric stent; definitive treatment; ureteroscopy; extracorporeal shock wave lithotripsy; cost; WAVE LITHOTRIPSY ESWL; URETEROSCOPY; STONES; CALCULI; TRENDS;
D O I
10.3390/jpm12111773
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: To analyze the differences in cost-effectiveness between primary ureteroscopy and ureteric stenting in patients with ureteric calculi in the emergency setting. Patients and Methods: Patients requiring emergency intervention for a ureteric calculus at a tertiary centre were analysed between January and December 2019. The total secondary care cost included the cost of the procedure, inpatient hospital bed days, emergency department (A&E) reattendances, ancillary procedures and any secondary definitive procedure. Results: A total of 244 patients were included. Patients underwent ureteric stenting (62.3%) or primary treatment (37.7%), including primary ureteroscopy (URS) (34%) and shock wave lithotripsy (SWL) (3.6%). The total secondary care cost was more significant in the ureteric stenting group (GBP 4485.42 vs. GBP 3536.83; p = 0.65), though not statistically significant. While mean procedural costs for primary treatment were significantly higher (GBP 2605.27 vs. GBP 1729.00; p < 0.001), costs in addition to the procedure itself were significantly lower (GBP 931.57 vs. GBP 2742.35; p < 0.001) for primary treatment compared to ureteric stenting. Those undergoing ureteric stenting had a significantly higher A&E reattendance rate compared with primary treatment (25.7% vs. 10.9%, p = 0.02) and a significantly greater cost per patient related to revisits to A&E (GBP 61.05 vs. GBP 20.87; p < 0.001). Conclusion: Primary definitive treatment for patients with acute ureteric colic, although associated with higher procedural costs than ureteric stenting, infers a significant reduction in additional expenses, notably related to fewer A&E attendances. This is particularly relevant in the COVID-19 era, where it is crucial to avoid unnecessary attendances to A&E and reduce the backlog of delayed definitive procedures. Primary treatment should be considered concordance with clinical judgement and factors such as patient preference, equipment availability and operator experience.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Effectiveness and Cost-Effectiveness of Antidepressants in Primary Care: A Multiple Treatment Comparison Meta-Analysis and Cost-Effectiveness Model
    Ramsberg, Joakim
    Asseburg, Christian
    Henriksson, Martin
    PLOS ONE, 2012, 7 (08):
  • [42] Cost-Effectiveness Analysis of the Diagnosis and Treatment of Primary Aldosteronism in Japan
    Sato, M.
    Morimoto, R.
    Seiji, K.
    Iwakura, Y.
    Ono, Y.
    Kudo, M.
    Satoh, F.
    Ito, S.
    Ishibashi, T.
    Takase, K.
    HORMONE AND METABOLIC RESEARCH, 2015, 47 (11) : 826 - 832
  • [43] Introduction of a dedicated colic clinic reduces referral to treatment times in patients managed expectantly with acute ureteric colic: a quality improvement project
    Cullen, Jack
    Kum, Francesca
    Scott, Luca
    Ismaylov, Vugar
    Chalokia, Ramandeep
    Willis, Susan
    BMJ OPEN QUALITY, 2023, 12 (03)
  • [44] Diagnostic accuracy of plain abdominal film in the management of acute ureteric colic-its time to rewrite history
    Pillai, R.
    Griffin, N.
    Grant, L.
    Higashi, Y.
    Shah, N.
    JOURNAL OF ENDOUROLOGY, 2007, 21 : A210 - A210
  • [45] COST-EFFECTIVENESS OF PRIMARY LIVER TRANSPLANTATION VERSUS HEPATOPORTOENTEROSTOMY IN THE MANAGEMENT OF BILIARY ATRESIA
    Raghu, Vikram
    Squires, James E.
    Mogul, Douglas
    Squires, Robert H.
    McKiernan, Patrick James
    Mazariegos, George V.
    Smith, Kenneth J.
    HEPATOLOGY, 2020, 72 : 427A - 428A
  • [46] Cost-effectiveness of Resonance® metallic ureteral stent compared with standard polyurethane ureteral stents in malignant ureteric obstruction: A cost-utility analysis
    Cooper, Dawn M.
    Lines, Rachel
    Shergill, Iqbal
    BJUI COMPASS, 2024, 5 (05): : 465 - 475
  • [47] A cost-effectiveness analysis of conservative versus surgical management for the initial treatment of stress urinary incontinence
    Richardson, Monica L.
    Sokol, Eric R.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 211 (05)
  • [48] Cost-effectiveness analysis of treatment options for acute otitis media
    Coco, Andrew S.
    ANNALS OF FAMILY MEDICINE, 2007, 5 (01) : 29 - 38
  • [49] THE COST-EFFECTIVENESS OF SULBACTAM-AMPICILLIN VERSUS MOXALACTAM IN THE MANAGEMENT OF ACUTE CHOLECYSTITIS
    ITO, MK
    GILL, MA
    YELLIN, AE
    BERNE, TV
    HESELTINE, PNR
    APPLEMAN, MD
    LEEDOM, JM
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 46 (04): : 747 - 754
  • [50] Cost-effectiveness of fomepizole versus ethanol in the management of acute ethylene glycol exposure
    不详
    CLINICAL TOXICOLOGY, 2005, 43 (06): : 691 - 691